News Sections
Eli Lilly Set To Start Trials On Alzheimer's Inhibitor
Updated May 5, 2013 12:05 AM | Filed under: Network Indiana
 Print    Archive    RSS

(INDIANAPOLIS) - Indianapolis-based Eli Lilly has announced Phase III testing of an inhibitor designed to treat Alzheimer's disease.

The company says 1,500 patients in the US and 21 other countries will be studied for nearly two years.

Researchers are trying to find out if the inhibitor can slow the progression associated with Alzheimer's by blocking an enzyme that can crate a protein which is believed to eventually kill off brain cells estimates show that 6 to 8% of people over age 65 are affected by Alzheimer's disease, totaling approximately 5 million people in the United States alone.

« Previous Article
Next Article »

 Print    Archive    RSS

Have a question or comment about a news story? Send it to

Advertise with 1340 AM WBIW
Find more about Weather in Bedford, IN
Advertise with 1340 AM WBIW

1340 AM WBIW, Bedford's Place To Talk. Serving Lawrence and surrounding counties since 1948!

© 2018 Ad-Venture Media, Inc. All Rights Reserved. and Listen Live Powered by HPC

Advertise  |  Careers  |  Contests  |  About  |  Feedback  |  Public File